Expression profile of NF-κB regulated genes in sporadic colorectal cancer patients

Abstract

Colorectal cancer (CRC) is the fourth leading worldwide cause of cancer-associated mortalities. Nuclear factor-κB (NF-κB) is a transcriptional regulator of multiple genes associated with CRC. Tumor tissue were compared with normal adjacent mucosa from 30 sporadic patients with CRC were investigated. A total of 8 non-CRC patients were analyzed as a control group. In the present study, the protein expression of NF-κB/p65 was detected by immunohistochemistry, and the gene expression profiles of cyclin D1 , prostaglandin-endoperoxide synthase 2, vascular endothelial growth factor A, matrix metallopeptidase 9, BCL2 apoptosis regulator, BCL2 like 1, nitric oxide synthase 2, tumor necrosis factor and arachidonate lipoxygenase were detected by reverse transcription-quantitative polymerase chain reaction. NF-κB/p65 and genes expression profiles were classified according to tumor-node-metastasis (TNM) clinicopathological parameters, followed by statistical analysis. Higher protein expression of NF-κB/p65 in the cytoplasm of tumor tissues compared with adjacent normal mucosa was reported; this increment was positively associated with all clinicopathological parameters, except for tumor localization site. The selected genes demonstrated a diverse associative pattern when analyzed with clinicopathological parameters. was positively associated with all TNM parameters and was negatively associated with all TNM parameters, thus indicating their importance as strong molecular biomarkers for CRC. According to these results, not all selected genes regulated by NF-κB/p65 show increased expression during CRC development, whereas the transcription factor did. The present study suggests that NF-κB/p65 overexpression is necessary for CRC establishment and progression, but its transcriptional activity is not sufficient to regulate all target genes in CRC. NF-κB/p65 and the gene expression profiles reported in the present study may be therapeutically useful. Considering the heterogeneity of the disease, the particular evaluation of these molecules may allow for the selection of proper diagnosis, treatment and follow-up for patients with sporadic CRC.

Localized Photothermal Ablation Therapy of Obstructive Rectal Cancer Using a Nanofunctionalized Stent in a Mouse Model

“…To further explore the molecular mechanism of the AuNP-coated SEMS-mediated PTA, mRNA levels of various tumor markers, carcinoembryonic antigen (Cea), mitogen-activated protein kinase 1 (Mapk1), c-Jun N-terminal kinase (Jnk), cyclin-dependent kinase 6 (Cdk6), transforming growth factor-beta (Tgf-β), cyclooxygenase 2 (Cox-2), p65, tumor necrosis factor-alpha (Tnf-α), and cluster of differentiation 133 (Cd133), − were examined by quantitative reverse-transcription polymerase chain reaction (qRT-PCR) (Table S1, Supporting Information). Among these, we found a significantly lower Mapk1 expression in group C ( p = 0.02) (Figure c), which was consistent with the reduced infiltration and smaller tumor size.…”

IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients

“…In cancer cells however, NF-κB pathway is often dysregulated so that cells could evade apoptosis and proliferate uncontrollably. In the context of colorectal cancer, NF-κB and some of its regulated genes, have been found to be expressed at higher levels in tumors samples, and appear to correlate with a worse prognosis ( 50 , 51 ). It has been shown that NF-kB induces transcription of many genes, including pro-inflammatory cytokines, such as IL-8, IL-6 and TNF-α ( 44 ).…”

The Clinicopathological Correlation of KRAS Mutation and PTEN Expression Status in Primary and Metastatic Colorectal Carcinoma

“…The final staining score was obtained by adding the staining intensity to the extent of staining. Scores equal to or greater than 3 were considered positive [ 12 , 13 ].…”